TD Ameritrade Investment Management’s BeOne Medicines Ltd ONC Stock Holding History

TD Ameritrade Investment Management’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-331	Closed	-$59K	–	538
2023 Q2	$59K	Sell	331 -90	-21%	-$20.7K	﹤0.01%	246
2023 Q1	$91K	Sell	421 -84	-17%	-$20.1K	﹤0.01%	230
2022 Q4	$111K	Sell	505 -145	-22%	-$26.6K	﹤0.01%	230
2022 Q3	$88K	Sell	650 -57	-8%	-$9.79K	﹤0.01%	253
2022 Q2	$114K	Sell	707 -96	-12%	-$15K	﹤0.01%	249
2022 Q1	$151K	Buy	803 +454	+130%	+$96.5K	﹤0.01%	257
2021 Q4	$95K	Buy	349 +200	+134%	+$67.5K	﹤0.01%	298
2021 Q3	$43K	Sell	149 -138	-48%	-$45.1K	﹤0.01%	344
2021 Q2	$98K	Buy	+287	New	+$95.1K	﹤0.01%	283
2020 Q4	–	Sell	-149	Closed	-$43K	–	665
2020 Q3	$43K	Buy	+149	New	+$35K	﹤0.01%	344

Other funds holding ONC

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

TD Ameritrade Investment Management's ONC Position: Q3 2023 in Review

TD Ameritrade Investment Management sold out of BeOne Medicines Ltd (ONC) in Q3 2023, closing a stake of 331 shares — an estimated $59K sold.

TD Ameritrade Investment Management first reported a position in ONC in Q3 2020 and held it in 10 quarters. The position peaked at $151K in Q1 2022. 201 funds tracked by Wall St. Rank hold ONC as of Q3 2023.

TD Ameritrade Investment Management reported no remaining BeOne Medicines Ltd position as of Q3 2023 after selling out during the quarter.
TD Ameritrade Investment Management sold 331 BeOne Medicines Ltd shares in Q3 2023, an estimated $59K.
TD Ameritrade Investment Management first reported a position in BeOne Medicines Ltd in Q3 2020 and held it in 10 quarters.
TD Ameritrade Investment Management's BeOne Medicines Ltd position peaked at $151K in Q1 2022.
201 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2023.

Based on TD Ameritrade Investment Management's 13F filing for Q3 2023.